Hugel Shares This Year's Core Strategies with Executives and Employees

On the 10th, at the Hugel Seoul office during the POA, Han Sun-ho, Vice President of Sales and Marketing Headquarters, is presenting the major achievements of last year. [Photo by Hugel]

[Asia Economy Reporter Lee Chun-hee] Hugel, a medical aesthetic specialized company, announced on the 11th that it held the first POA (Plan of Action) of the year at its Seoul office on the 10th.

This POA was held face-to-face with about 70 executives and employees from the sales and marketing headquarters, including the domestic business division, marketing division, and cosmetics division. It was a time to review last year's major achievements and best practices, and to share this year's business goals and key strategies by product category.

Hugel announced plans to strengthen market competitiveness through sales and marketing innovation this year. The CE (Commercial Excellence) strategy will be further segmented to drive sales expansion by product and secure new clients. In addition, it plans to build an omni-channel that harmonizes face-to-face and non-face-to-face sales, seeking opportunities to provide customers with diverse information without restrictions of time and space.

It also aims for mutual growth in domestic and overseas markets. While solidifying the domestic position of the botulinum toxin (BTX) product 'Botulax' and HA filler 'The Chaeum,' it has also prepared specific activities to expand market share in China and Europe and to prepare for entry into the U.S. market.

Efforts to secure new growth engines are also accelerating. It will expand its domestic business area by raising awareness of the new brand 'Byrizen' and adding to the lineup of the absorbable suture brand 'Blue Rose.' Along with establishing differentiated strategies by channel for the functional cosmetics 'Wellage' and hospital/clinic specialized cosmetics '[PR]4,' it plans to continuously launch new products to expand its presence in the cosmetic market.

A Hugel official said, "This year, we will implement more efficient and advanced sales and marketing through the introduction of new strategies and systems to leap forward as a global leading company in the medical aesthetic field," adding, "We will continue sustainable growth in line with the With Corona and Post Corona era."